Foreign companies now have more confidence in India’s patent system, but the economic boom is yet to produce much home grown innovation, says a new report.
Two Framework Programme 6 (FP6) schemes specifically devised to promote the development of the European Research Area failed to deliver, according to a new report.
Roche has granted Russian start-up Viriom Ltd a licence to develop and commercialise potential novel treatments for HIV/AIDS patients in Russia, Ukraine, Belarus and Kazakhstan.
A £37 million Bioscience Campus is to be set up at GlaxoSmithKline’s site at Stevenage, UK, with funding from the government, GlaxoSmithKline, and other partners.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.